EUVIMEDEUVIMED entdecken
Crossref

Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression

J. Benatar

Heart, Lung and Circulation · 2026-06 · 35 · S48

DOI: 10.1016/j.hlc.2026.04.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-06. Verfasst von J. Benatar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Benatar, J. (2026). Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression. Heart, Lung and Circulation, 35, S48. https://doi.org/10.1016/j.hlc.2026.04.059

Vancouver

Benatar J. Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression. Heart, Lung and Circulation. 2026;35:S48. doi:10.1016/j.hlc.2026.04.059

BibTeX
@article{Benatar2026,
  author = {Benatar, J.},
  title = {Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression},
  journal = {Heart, Lung and Circulation},
  year = {2026},
  volume = {35},
  pages = {S48},
  doi = {10.1016/j.hlc.2026.04.059}
}
Kostenlos starten →